Real-world study: A potential new approach to effectiveness evaluation of traditional Chinese medicine interventions

Journal of Chinese Integrative Medicine

Volumn 8, Issue 4, 2010, Pages 301-306

  Tian, Feng ^a   Xie, Yan Ming ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Chinese herbal drug; Drug evaluation; Investigational new drug; Randomized controlled trial; Real world study

Indexed keywords

CHINESE DRUG;

CHINESE MEDICINE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INFORMATION PROCESSING; METHODOLOGY; OUTCOME ASSESSMENT; POSTMARKETING SURVEILLANCE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RANDOMIZED CONTROLLED TRIAL; REVIEW;

DRUGS, CHINESE HERBAL; MEDICINE, CHINESE TRADITIONAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 77950915265     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20100401     Document Type: Review

References (19)

1. Sharpe N. Clinical trials and the real world: selection bias and generalisability of trial results. Cardiovasc Drugs Ther. 2002; 16(1): 75-77. (Pubitemid 34606615)
2. Grapow MT, von Wattenwyl R, Guller U, Beyersdorf F, Zerkowski HR. Randomized controlled trials do not reflect reality: real-world analyses are critical for treatment guidelines. J Thorac Cardiovasc Surg. 2006; 132 (1): 5-7. (Pubitemid 43913875)
3. Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, Birtwhistle R, Lam M, Seguin R. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol. 2003; 3: 28. (Pubitemid 38809195)
4. Karanicolas PJ, Montori VM, Devereaux PJ, Schunemann H, Guyatt GH. A new "mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol. 2009; 62(5): 479-484.
5. Fox KAA. An introduction to the global registry of acute coronary events: GRACE. Eur Heart J. 2000; 2 (Suppl F): F21-F24.
6. Mossello E, Tonon E, Caleri V, Tilli S, Cantini C, Cavallini MC, Bencini F, Mecacci R, Marini M, Bardelli F, Sarcone E, Razzi E, Biagini CA, Masotti G. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study. Arch Gerontol Geriatr Suppl. 2004; (9): 297-307.
7. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani M, Carolei A, Cerveri I, Duran-Tauleria E, Gislason D, Gulsvik A, Jogi R, Marinoni A, Martinez- Moratalla J, Vermeire P, de-Marco R. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007; 120(6): 1360-1367. (Pubitemid 350225685)
8. Gale CP, Manda SOM, Batin PD, Weston CF, Birkhead JS, Hall AS. Predictors of in-hospital mortality for patients admitted with ST-elevation myocardial infarction: a real-world study using the Myocardial Infarction National Audit Project (MINAP) database. Heart. 2008; 94(11): 1407-1412.
9. Lasalvia A, Bonetto C, Cristofalo D, Tansella M, Ruggeri M. Predicting clinical and social outcome of patients attending real world mental health services: a 6-year multi-wave follow-up study. Acta Psychiatr Scand Suppl. 2007; (437): 16-30. (Pubitemid 350029198)
10. Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS. A simple and valid tool distinguished efficacy from effectiveness studies. J Clin Epidemiol. 2006; 59 (10): 1040-1048. (Pubitemid 44374310)
11. Fleischhacker WW, Goodwin GM. Effectiveness as an outcome measure for treatment trials in psychiatry. World Psychiatry. 2009; 8(1): 23-27.
12. Magliano L, Fiorillo A, Malangone C, Rosa CD, Maj M. Patient functioning and family burden in a controlled, real-world trial of family psychoeducation for schizophrenia. Psychiatr Serv. 2006; 57(12): 1784-1791. (Pubitemid 46051335)
13. Vidal JS, Lacombe JM, Dartigues JF, Pasquier F, Robert P, Tzourio C, Alperovitch A. Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients. Alzheimer Dis Assoc Disord. 2008; 22 (2): 125-130.
14. Kraemer HC. "Rules" of evidence in assessing the efficacy and effectiveness of treatments. Dev Neuropsychol. 2003; 24(2-3): 705-718.
15. GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001; 141(2): 190-199.
16. Farahani P, Levine M, Gaebel K, Khalidi N, Wang ECY. Community-based evaluation of etanercept in patients with rheumatoid arthritis. J Rheumatol. 2006; 33(4): 665-670.
17. Nash JM, McCrory D, Nicholson RA, Andrasik F. Efficacy and effectiveness approaches in behavioral treatment trials. Headache. 2005; 45(5): 507-512. (Pubitemid 40847173)
18. Ernst E, Canter PH. Limitations of "pragmatic" trials. Postgrad Med J. 2005; 81(954): 203.
19. Simon G, Wagner E, Vonkorff M. Cost-effectiveness comparisons using "real world" randomized trials: the case of antidepressant drugs. J Clin Epidemiol. 1995; 48(3): 363-373.